Loading...
XCSE
SMSMED
Market cap12mUSD
Jul 10, Last price  
2.93DKK
1D
1.03%
1Q
-2.33%
IPO
-43.65%
Name

Scandinavian Medical Solutions A/S

Chart & Performance

D1W1MN
XCSE:SMSMED chart
P/E
3,133.52
P/S
0.33
EPS
0.00
Div Yield, %
Shrs. gr., 5y
0.32%
Rev. gr., 5y
42.38%
Revenues
245m
+8.28%
31,195,45741,948,68471,637,868110,529,908191,191,577226,682,000245,442,000
Net income
26k
-99.67%
3,038,7294,511,1158,157,07411,372,74412,224,3147,787,00026,000
CFO
-13m
L
9,380,0794,024,435-10,572,905-8,365,5293,392,000-13,413,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Scandinavian Medical Solutions A/S (SMS), a global entity established in 2018 and headquartered in Aalborg, Denmark, specializes in medical imaging equipment. The company provides a comprehensive array of diagnostic and therapeutic devices, encompassing CATH lab systems, CT scanners, linear accelerators, mammography units, PET/CT and SPECT/CT systems, X-ray machines, ultrasound equipment, MRI scanners, GAMMA/SPECT systems, C-arms, mobile X-ray units, R/F systems, and DEXA scanners, among others. Furthermore, SMS supplies critical spare parts for specific equipment types including CT, MRI, CATH lab, X-ray, mammography, PET/CT, and C-arm systems. Beyond sales, their offerings extend to equipment rental and technical support services. SMS serves a broad clientele, including hospitals, various medical clinics, and distributors worldwide.
IPO date
Nov 03, 2021
Employees
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT